Seres therapeutics to participate in oppenheimer 33rd annual healthcare conference

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, today announced that eric shaff, president and chief executive officer of seres therapeutics, will provide a corporate presentation at the oppenheimer 33rd annual healthcare conference on wednesday, march 15, 2023 at 8:40 a.m. et. an audio webcast of the presentation will be available under the “investors and news” section of seres' website.
MCRB Ratings Summary
MCRB Quant Ranking